@article{29b60e807ad6450c887cbb709326fb89,
title = "To be or not 2b? to see or not 2c? Alas, the clock is ticking on TICI",
keywords = "angiography, stroke, thrombectomy",
author = "Kallmes, {David F.} and Rabinstein, {Alejandro A.} and Gounis, {Matthew J.}",
note = "Funding Information: Competing interests DFK: Consulting for Medtronic (all funds to the institution), ownership stake in Marblehead Medical, and has received research support from Medtronic, MicroVention, NeuroSigma, Shape Memory Therapeutics, IndumedX, Sequent Medical, Neurogami, and NeuroSave. AAR: Received funding from DJO Global. MJG: Has been consultant on a fee-per-hour basis for Codman Neurovascular, InNeuroCo, Medtronic Neurovascular, and Stryker Neurovascular; holds stock in InNeuroCo; and has received research support from the National Institutes of Health (NIH), Anaconda, Codman Neurovascular, Gentuity, InNeuroCo, Microvention, Medtronic Neurovascular, MIVI Neurosciences, Neuravi, Philips Healthcare, InNeuroCo, Rapid Medical, R92M, Stryker Neurovascular, The Stroke Project, and the Wyss Institute.",
year = "2018",
month = apr,
doi = "10.1136/neurintsurg-2017-013521",
language = "English (US)",
volume = "10",
pages = "323--324",
journal = "Journal of neurointerventional surgery",
issn = "1759-8478",
publisher = "BMJ Publishing Group",
number = "4",
}